Image

Weightbearing Restrictions on Postoperative Outcomes Following Arthroscopic Surgery for FAI

Weightbearing Restrictions on Postoperative Outcomes Following Arthroscopic Surgery for FAI

Recruiting
16-50 years
All
Phase N/A

Powered by AI

Overview

The purpose of this single-blinded (assessor) randomized trial is to compare patient-reported, clinical and functional outcomes in patients randomized to weight-bearing as tolerated (WBAT) or partial weight-bearing (PWB) restrictions following arthroscopic surgery for femoroacetabular impingement (FAI) up to 12-months postoperative.

Description

The purpose of this single-blinded (assessor) randomized trial is to compare patient-reported, clinical and functional outcomes in patients randomized to weight-bearing as tolerated (WBAT) or partial weight-bearing (PWB) restrictions following arthroscopic surgery for femoroacetabular impingement (FAI) up to 12-months postoperative. The primary objective is to compare the effects of WBAT or PWB restrictions on PROMS (International Hip Outcome Tool (iHOT33)) and clinical measures following arthroscopic intervention for FAI up to one-year post-operative. The secondary objective will be to assess differences in return to sport (RTS) PROMS, functional performance, and lower extremity kinetics, kinematics, and muscle activity during in patients randomized to either WBAT or PWB at six- and 12-months post-operative. The goal will be to answer if there are differences between a WBAT versus PWB rehabilitation protocol on patient-reported quality of life as measured by the International Hip Outcome Tool (iHOT33) at 12-m post-operative for patients undergoing primary hip arthroscopy for the treatment of FAI.

Eligibility

Inclusion Criteria:

  • 16 - 50 years of age at time of surgery
  • Diagnosis of FAI (cam, pincer, mixed) based on the 2016 Warwick Agreement. All 3 criteria below must be met:
    1. Symptoms of motion- or position-related pain in the hip or groin
    2. Clinical signs consistent with FAI such as: decreased hip flexion and internal rotation, or positive impingement sign
    3. Radiographic evidence (on BOTH x-ray AND non-contrast MRI) of intra-articular pathology consistent with FAI as determined by the treating surgeon.
  • Failed conservative interventions of at least 3 months (i.e. physiotherapy)
  • Have symptom relief with intra-articular injection of local anaesthetic
  • Unilateral or bilateral surgical intervention (note: unilateral required to ensure the weight bearing guidelines are followed)
  • Are willing to be followed for 12 months post-operative.

Eligibility for 'return to sport' cohort:

        Additional assessment measures related to return to sport will be collected on the patient
        who meet the following criteria:
          -  are or were previously actively involved in sport as indicated by a pre-operative Hip
             Sports Activity Scale score of four of greater
          -  indicate a post-operative goal to return to sport following their procedure
        Exclusion Criteria:
        Clinical:
          -  Previous surgery on the affected hip, or other major lower extremity orthopaedic
             surgery
          -  Active joint or systemic infection, significant muscle paralysis, significant lower
             extremity or medical comorbidity that could alter the effectiveness of the surgical
             intervention (e.g. polymyalgia rheumatica)
          -  Unable to speak or read English/French
          -  Unable or unwilling to be followed for 1 year or complete functional testing
          -  Presence of chronic pain syndromes
          -  History of pediatric hip disease (i.e. Slipped Capital Femoral Epiphysis,
             Legg-Calve-Perthes Disease)
          -  Ongoing litigation or compensation claims related to the hip (including Workers'
             Compensation)
        Radiographic:
          -  Osteoarthritis greater than Tönnis Grade 1 on affected hip
          -  Lateral central edge angle <19°
          -  Dysplasia in patients with broken Shenton line (i.e. Severe acetabular deformity
             present)

Study details
    Femoro Acetabular Impingement

NCT05280899

Panam Clinic

18 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.